how effective is oral tirzepatide vs Injection: Pros, Cons & Side Effects Oral Tirzepatide: What the Research

Mima A, Hiraoka-Yamomoto J, Li Q, Kitada M, Li C, Geraldes P, et al

It increases risk of nausea, vomiting, and other GLP-1 side effects

So this being a, a positive superiority trial, all we mean by that is that a difference was shown between the two strategies

The girls at the front desk were lovely as well and so helpful

hence, the 2025 ADA Standards of Care recommend the regular assessment of eGFR and spot urinary albumin-to-creatinine ratio (spot UACR) in both T1DM patients (after five years of their initial DM diagnosis and annually thereafter) and T2DM patients (at the time of their first diagnosis and annually thereafter)